Endocrinology Flashcards

1
Q

regulation of thyroid axis

A

TRH

  • released from hypothalamus
  • increases TSH production and secretion

TSH

  • released from anterior pituitary
  • stimulates thyroid hormone synthesis
  • > via TSH-receptor
  • > G protein coupled
  • > increases cAMP

thyroid hormones

  • high levels
  • > inhibit TRH and TSH
  • low levels
  • > increase basal TSH and responsiveness to TRH

other

  • cold
  • > increased TRH secretion
  • emotions
  • > excitement/anxiety = increase in TRH
  • smoking
  • > decreases action of thyroid hormones
  • estrogen
  • > increases thyroxine binding protein
  • > increases total thyroid hormone
  • androgen
  • > do the opposite
  • drugs (eg. phenytoin)
  • > interfere with thyroid hormone protein binding
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

thyroid hormone synthesis

A

iodine

  • source
  • > fish, seaweed and seafood
  • > diary products
  • > iodised salt
  • blood transport
  • > bound to albumin
  • basolateral transport
  • > Na Iodide Symporter (NIS)
  • > increased expression in deficiency
  • > decreased expression in excess
  • apical transport
  • > pendrin

in lumen (colloid)

  • organification
  • > oxidation by thyroid peroxidase
  • > iodide -> iodine
  • bind to tyrosine residues of thyroglobulin
  • > monoiodotyrosine
  • > diiodotyrosine
  • ester bonds join iodotyrosines
  • > catalysed by thyroid peroxidase
  • > MIT + DIT = T3
  • > DIT + DIT = T4
  • thyroglobulin transported by into follicular cell

inside follicular cell

  • T3/T4 released from thyroglobulin within lysosomes
  • > MIT and DIT recycled

transported into blood

  • serum binding proteins
  • > thyroxine binding protein
  • > albumin
  • 99% protein bound
  • > higher proportion of T3 free
  • T4 produced 20x more than T3
  • > T3 binds to receptor with higher affinity
  • T3 is more potent hormone
  • > T4 converted to T3 by deiodinases
  • > types I, II, III
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

thyroid hormone action

A

predominately gene transcription

  • T3/4 binds to nuclear thyroid hormone receptors
  • > alpha and beta
  • bind to thyroid response elements
  • > promoter region of target genes
  • > increase or decrease gene expression

metabolism

  • greatly increased by thyroid hormones
  • > food utilisation
  • > protein synthesis and catabolism
  • mitochondria
  • > increase in number and size of
  • > increase in ATP formation
  • ion transport
  • > increases activity of Na/K ATPase ->generates heat
  • > leaky membranes to Na drives Na/K ATPase further
  • carbohydrates
  • > increased insulin secretion and glucose uptake
  • > increase glycolysis/gluconeogenesis
  • lipids
  • > increased lipolysis
  • > increased fatty acid oxidation
  • > increased free fatty acids, but decreased cholesterol, triglycerides and phospholipids
  • > increases LDL receptor on liver
  • > hypo results in fatty liver and atherosclerosis
  • weight
  • > increase and decrease with hormone level

cardiac

  • production of metabolic waste and consumption of O2
  • > vasodilation and peripheral blood flow
  • > increases CO
  • heart rate
  • > increases excitability of the heart -> increase HR
  • contractility
  • > initially increased
  • > in chronicity leads to decompensation and failure
  • blood pressure
  • > mean pressure remains normal
  • > pulse pressure widened

resp

  • increased O2 consumption with metabolism
  • > tachypnea
  • > increased tidal volume

GI

  • increased appetite
  • increased motility and gastric secretions
  • > diarrhoea

Muscles

  • hyper = initially increased reflexes
  • > weakened with chronicity due to catabolism
  • hypo = weak and sluggish reflexes

Neuro

  • racing thoughts
  • anxiety, paranoia, worry
  • tremor
  • > due to excitability

sleep

  • increased metabolism = tiredness
  • increased excitability = insomnia

sexual function

  • men
  • > hypo = loss of libido
  • > hyper = impotence
  • women
  • > hypo = menorrhagia/amenorrhea, irregularity
  • > hypo = loss of libido

growth

  • skeletal growth in children
  • brain development in neonate and fetus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

high/low TSH causes

A

High TSH

  • hypothyroidism
  • TSH secreting pituitary tumour
  • thyroid hormone resistance

Low TSH

  • thyrotoxicosis
  • first trimester pregnancy
  • > suppression by hCG
  • after treatment for hyperthyroid
  • medications
  • > glucocorticoids
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

causes of hyperthyroidism

A

IGNITE

  • Inflammation (thyroiditis)
  • > infection
  • > radiation
  • > amiodarone
  • > occasionally early silent or subacute thyroiditis

-Graves

  • Neoplasia
  • > hydatiform mole
  • > chorciocarcinoma
  • Iodine induced
  • > jod basedow phenomenon in autonomous nodules
  • > contrast
  • > amiodarone
  • Toxic nodules and adenoma
  • > gain of function mutations giving autonomy
  • > TSH receptor
  • > alpha subunit of stimulating G protein
  • Exogenous
  • > thyroxine replacement
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

causes hypothyroidism

A

II CHRIST

  • Iodine
  • > deficiency most common
  • > excess (wolff chaikoff effect)
  • Infiltration
  • > reidells thyroiditis (fibrous)
  • > sarcoid/amyloid/haemochromatosis
  • Central (rare)
  • > secondary = anterior pituitary
  • > tertiary = hypothalamus
  • Hashimotos
  • Resistance (rare)
  • > mutation in nuclear receptor for T3
  • Iatrogenic
  • > radiation
  • > surgery

-Subacute/silent thyroiditis

  • Transient
  • > ->withdrawal of exogenous
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

symptoms of hyperthyroidism

A

SWEATTIIINGG

  • skin
  • > sweaty
  • > warm
  • > onycholysis
  • > alopecia
  • > thyroid acropatchy in graves
  • weight loss
  • eyes
  • > staring
  • > lid lag
  • > exophthalmos in graves
  • appetite increased
  • tachycardia
  • tremor
  • insomnia
  • intolerance of heat
  • irregular menstruation
  • neuro
  • > nervous
  • > emotional lability
  • GI
  • > diarrhoea and malabsorption
  • goitre
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

symptoms hypothyroidism

A

MOM’S SO TIRED

  • memory loss
  • obesity
  • menstrual irregularity
  • slowness (speech/mental and physical)
  • skin
  • > dry, coarse (including hair)
  • > cool
  • > dry
  • > myxedema
  • output (cardiac) decreased
  • > reduced exercise tolerance
  • > SOB
  • tiredness
  • intolerance of cold
  • reflexes sluggish
  • eyes
  • > periorbital oedema
  • depression
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

thyroid storm aetiology, manifestations, management

A

cause

  • usually in patients with longstanding hyperthyroidism
  • > graves
  • > toxic nodules or adenoma
  • thyroid surgery
  • trauma
  • infection
  • acute iodine load
  • parturition

clinical manifestations

  • exaggerated presentation of thyrotoxicosis
  • cardiovascular
  • > tachycardia
  • > arrhythmias
  • > cardioresp failure
  • fever
  • altered mental status
  • > anxiety
  • > delirium/psychosis
  • > coma

lab manifestations

  • TSH and thyroid hormone levels are not greatly altered
  • free T3 and T4 greatly increased

management

  • in ICU
  • same as usual thyrotoxicosis treatment but larger doses
  • > beta blockers
  • > glucocorticoids
  • > iodine solution
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what is sick euthyroid syndrome

A

any acute illness can cause abnormalities in circulating TSH or thyroid hormones in the absence of thyroid disease
-thought to be due to release of cytokines such as IL-6

low T3 syndrome

  • most common
  • features
  • > normal TSH and T4
  • > decrease in total and unbound T3
  • cause
  • > impaired deiodination of T4 in the periphery
  • > decreased clearance of reverse T3

low T4 syndrome

  • very sick patients
  • type 3 deiodinase
  • > increased expression in muscle and liver with decreased tissue perfusion
  • accelerates T3 and 4 metabolism
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Graves aetiology and autoimmunity

A

Aetiology

  • genetic
  • > eg. HLA-DR polymorphism
  • environmental
  • > smoking
  • > stress
  • > post partum
  • > iodine (amiodarone, contrast)

Autoimmunity

  • anti bodies to TSH receptor
  • > thyroid stimulating Ig (TSI)
  • > activate receptor
  • also antibodies to
  • > thyroid peroxidase
  • > thyroglobulin
  • spectrum
  • > graves, hashimotos, silent thyroiditis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Graves pathophys and path

A

Pathophys

  • insult or infection to thyroid epithelial cell
  • infiltrating T cells
  • > produce interferon gamma
  • expression of HLA class II molecule
  • > initiates autoimmune cascade
  • TSI
  • > hormone over production
  • > follicular cell hypertrophy and hyperplasia

pathology

  • thyroid diffusely englarged
  • > follicular hyperplasia
  • > intracellular colloid
  • > reduced follicular colloid
  • lymphocytic infiltration
  • > predominately T cells
  • > some B cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

pathophys of pretibial myxoedema and orbitopathy

A

fibroblasts

  • express TSH receptor
  • > stimulation by TSI
  • also activated by local cytokines from lymphocytes
  • produces GAGs
  • > in mucinous oedema
  • > dermis = myxedema
  • > retro-orbital = proptosis

also in orbitopathy

  • invasion of muscles
  • > lymphocytes
  • > mast cell
  • > macrophages
  • causing
  • > impaired venous return
  • > pressure on optic nerve
  • > ulceration

also in myxedema

  • non pitting oedema
  • > fragmentation of dermal collagen
  • > compression of lymphatics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

aetiology, pathophys and path of hashimotos

A

aetiology

  • genetic
  • > HLADR polymorphisms
  • > CTLA-4 polymorphisms
  • environmental
  • > pregnancy
  • > smoking
  • > excessive iodine intake

pathophys

  • antibodies
  • > TPO/Tg = secondary role fix complement/membrane attack complex
  • > TSH-R = blocking antibody
  • lymphocytes
  • > CD8 cytotoxic t cells destruction
  • > cytokines, interferon gamma = apoptosis

path

  • profuse lymphocytic infiltration
  • > both T and B cell
  • > within follicle = peripolesis
  • lymphoid germinal centers
  • destruction of thyroid follicles
  • > absence of colloid
  • > varying degrees of fibrosis
  • progression to atrophic in chronicity
  • > more extensive fibrosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

autoimmune associations thyroid disease

A

CRASHPADS

  • coeliac
  • rheumatoid
  • alopecia areata
  • srojens
  • hepatitis (chronic)
  • pernicious anaemia
  • addisons
  • diabetes (type I)
  • SLE

+vitiligo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

myxoedema aetiology and clinical manifestations

A

Cause

  • can occur in any disease causing hypothyroidism
  • trigger
  • > acute infection
  • > surgery
  • > cold exposure

Clinical manifestations

  • neuro
  • > confusion, lethargy, obtunted
  • > (can be myxedema madness with psychosis)
  • > seizures
  • hyponatraemia
  • > contributes to neuro effects
  • hypothermia
  • hypoventilation
  • > resp acidosis
  • hypoglycaemia
  • cardiac
  • > bradycardia
  • > narrowed pulse pressure with diastolic HTN
17
Q

Graves investigation findings

A

Graves

  • low TSH
  • T3/4
  • > elevated free
  • > total may be misleading
  • > high T3:T4 or FT3:T4 (low in thyroiditis)
  • antibody immunoassay
  • > presence of TSH receptor antibodies
  • > 80% have TPO antibodies
  • > most have Tg antibodies
  • radioiodine uptake
  • > homogenous uptake
  • scintigraphy
  • > diffuse uptake
  • ultrasound
  • > highly vascular
  • MRI orbit
  • > thickening intra-orbital muscles
18
Q

Hashimotos investigation findings

A

Hashimotos

  • high TSH
  • T3/T4
  • > T4 down
  • > T3 often normal due to increased deiodination
  • antibodies (present in >95%)
  • > TPO
  • > Tg
19
Q

investigations thyroid disease

A

ECG
glucose

FBC
-graves = microcytic + thrombocytopaenia
-hashimotos = normocytic or macrocytic 
Iron studies
LFTs
-bili elevated in graves
Lipids
-hypo = elevated triglycerides/cholesterol
Coags

Thyroid function tests

  • TSH as screener
  • > unbound T4 and follow up with T3
  • antibodies
  • > TPO
  • Tg
  • TSH-R

Consider

  • nodules
  • > ultrasound
  • goiter
  • > radioiodine uptake
  • > scintigraphy
  • MRI orbit in graves
20
Q

treatment hypothyroidism

A
  • levothyroxine
  • > prohormone (T4)
  • > deoidinated in periphery to T3
  • > 70-80% of dose is absorbed
  • > long half life (one week) -> once daily = allows steady state
  • adverse effects
  • > rare
  • > allergy to capsule filler
21
Q

treatment hyperthyroidism

A
  • beta blockers
  • thionamides
  • > block oxidation of iodine in thyroid
  • > rash, urticaria, arthralgias
  • > granulocytopenia/agranulocytosis
  • radioiodine ablation
  • > capsule or oral solution
  • > extensive tissue damage within 4 months
  • > can cause permanent hypothyroidism
  • surgery
  • > permanent hypothyroidism
  • > iatrogenic hypoparathyroidism
  • > recurrent laryngeal nerve damage
22
Q

complications diabetes

A

Microvascular:

  • nephrology
  • retinopathy
  • neuropathy

Macrovascular:

  • CAD
  • CCF
  • PAD
  • CVD

Non Vascular (FUDGIE):

  • Foot (amputation, ulceration, claw/hammer toes, charcot, callous)
  • Urological (cystopathy, UTIs, sexual dysfunction, retrograde ejaculation)
  • Dermatological (xerosis, pruitis, poor healing, bullosis diabeticorum, diabetic dermopathy)
  • Gastrointestinal (gastroparesis, diarrhoea, constipation)
  • Infection (all infections, skin, pulmonary, fungal)
  • Eye (glaucoma, cataracts)
23
Q

ddx diabetes

A

Type 1

  • younger
  • underweight
  • ketotic
  • low C peptide
  • antibodies

LADA (>30, non obese, respond to glucose therapy but decline, low c peptide, antibodies)

Type 2

  • picked up in screening
  • overweight
  • non ketotic
  • initial response to glucose lowering drugs
  • normal C peptide
  • no antibodies

HHS or DKA

Monogenic:
-MODY maturation onset diabetes of the young (strong fam hx, non obese, non ketotic, responds to glucose therapy, c peptide normal, no antibodies, confirmed by genetics)

Exocrine pancreas

  • cystic fibrosis
  • hereditary haemochromatosis
  • chronic pancreatitis

Other (CVD GAPS)

  • Cushings
  • Viral (unlikely, HVC)
  • Drugs (many, glucocorticoids, anti-HTN like thiazides)
  • glucagonoma
  • acromegaly
  • pheochromocytoma
  • somatostatinoma
24
Q

investigations diabetes

A

Need to repeat:

  • Random plasma glucose
  • Fasting (8hrs) plasma glucose
  • HbA1c
  • 2hr glucose tolerance test (75g oral glucose)

Islet Cell Antibodies (2 of):

  • insulin
  • glutamic acid decarboxylase 65 (GAD65)
  • zinc transporter (ZnT8)
  • Islet antigens (IA2, IA2beta)

C peptide

Urinary ketones

Other

  • LFTs
  • Lipids
  • EUCs
  • urinalysis and urine albumin:creatinine
  • ECG
25
Q

diabetes targets

A

Individualise targets and avoid hypoglycaemia

HbA1c:

  • general = <7%
  • short duration without medication = <6%
  • with complications = 8%

Blood glucose:

  • fasting = 4-8mmol/L
  • post prandial = <10mmol/L
26
Q

type 2 diabetes glucose monitoring

A

Glycaemic control usually assessed by HbA1c.

Ketone monitoring is usually unnecessary, save SGLT-2 inhibitors when sick.

Blood glucose self monitoring (with a glucose strip and blood glucose monitor)

  • used when treated with insulin or sulfonylureas.
  • can be used in absence of these medications to educate about effect of dietary intake and exercise, to assist with reinforcement and motivation, when sick or pre-surgery, when taking drugs (eg. corticosteroids) or with major lifestyle changes

Continuous glucose monitoring can be used in patients using insulin.

27
Q

DKA pathophys

A

Decrease in insulin, increase in counter-regulatory hormones (glucogon, cortisol, catecholamines, growth hormone). Particularly balance between insulin and glucagon.
Low insulin and high glucagon decreases hepatic level of fructose-2, 6-bisphosphate, thus increasing the activity of fructose-1, 6-bisphosphatase and decreasing the activity of phosphofructokinase-1.
In addition, the ratio glucagon to insulin increases the activity of phosphoenolpyruvate carboxykinase and decreases the activity of pyruvate kinase. This shifts the handling of pyruvate towards gluconeogenesis and away from glycolysis.
There is also an increase in glycogenolysis and the low levels of insulin reduces expression of the Glut-4 glucose transporter, which decrease glucose uptake.
At the same time, there is an increase in lipolysis and beta oxidation, forming Acetyl Coa, available as an energy substrate. Overtime there is a buildup in ATP, decreasing flux through the electron transport chain and increasing available NADH which inhibits the krebs cycle and increases levels of acetyl coa. Acetyl CoA does not inhibit beta oxidation, so it continues to build up and is diverted towards ketogenesis, with the formation of acetoacetate, which can be converted to D-beta-hydroxybutyrate or acetone. At physiological pH, these ketone bodies exist as keto acids and are neutralised by bicarbonate. As bicarb is depleted, ketoacidosis develops.

28
Q

HHS ddx

A

Provisional:

  • HHS or DKA due to polydypsia, polyuria
  • HHS favoured due to absence of nausea, vom, abo pain and most prominent feature is drowsiness

Encephalopathies

  • hypernatraemic
  • hypogylcaemic (insulin)
  • septic
  • electrolyte deficiency

Encephalitis

Meningitis

Drugs and alcohol

  • intoxication
  • withdrawal (wernicke’s)
  • anticholinergic effects

Unlikely:

  • sagittal sinus thrombosis
  • subacute subdural
  • brain tumour
  • non-dominant hemisphere stroke
  • depression
  • dementia
29
Q

investigations pituitary mass

A
  • FBC (anaemia in hypothyroid, hypocortisol, hypogonadism)
  • EUC (hyponatraemia in ACTH deficiency)
  • serum prolactin
  • insulin like growth factor 1
  • 24 hour urinary free cortisol
  • late-night salivary cortisol

Consider

  • LH, FSH (gonadotroph)
  • TSH and T4
  • beta HcG for suspected germ cell tumour

Imaging

MRI (with gadolinium enhancement)

  • causes of pituitary mass usually take up gadolinium more than surrounding tissue but less than normal.
  • If mass is seen as seperate from rest of pituitary it is unlikely to be adenoma.
  • cysts may be enhanced in T2 and hypointense T1.
  • meningioma = homogeneous uptake
  • craniopharyngioma = solid and cystic with enhancement of solid
30
Q

diagnostic criteria diabetes

A

Symptomatic (polyuria, polydypsia, impaired vision, DKA HHS) with random >11.1

HbA1c 6.5%

Fasting plasma glucose >7.0

2hr glucose tolerance >11.1

Impaired:

  • fasting plasma 5.6-6.9
  • glucose tolerance 7.8-11
  • HbA1c 5.7-6.4

Results need to be repeated

31
Q

risk factors diabetes

A

For both:
-family hx

Type 2:

  • older age
  • overweight
  • physical inactivity
  • HTN
  • dyslipidaemia
  • CVD
  • racial
  • gestational diabetes
  • pre diabetes
  • polycystic ovary syndrome
32
Q

hx diabetes

A

Typical symptoms
-polyuria, polydypsia, fatigue, weakness, nocturia

Acute complications

  • DKA (nausea, vom, abdo pain)
  • HHS (significant fatigue)
Chronic complications (Type 2)
-blurry vision, paresthaesias, infections (skin, UTI), weight loss

Risk factors

Past MHx

  • hospitalisation (DKA, HHS)
  • presence of complications
  • hypoglycaemic episodes
  • CVD

Medications
-use, compliance, efficacy, side effects

Psychosocial

  • smoking
  • diet
  • functional impairment, distress
33
Q

Exam diabetes

A

Exam

  • full cardiovascular including peripheral vascular
  • examination of the feet, including assessment of ankle reflexes, pulses, vibratory sensation, and monofilament touch sensation
  • dilated retinal examination
  • skin for infections and acanthosis nigricans
34
Q

treatment DKA

A

Goals

  • restore circulating blood volume
  • inhibit lipolysis, gluconeogenesis and ketogenesis
  • address precipitating factors
  • re-establish normal physiology and electrolyte balance

Issues

  • acidosis
  • dehydration
  • hypokalaemia (hyper)

Fluids IV

  • start early
  • resuscitate, restore, maintain

Insulin IV

  • infusion @ o.1unit/kg/hr
  • don’t drop BG >5mmol/L (cerebral oedema)
  • aim for 10-15mmol/L
  • begin 5% glucose infusion, maintain insulin infusion
  • goal is to address acidosis, not hyperglycaemia
  • hyperglycaemia corrected in 4-8hrs but acidosis may take 24

Potassium

  • total body depletion
  • insulin and correction of acidosis drives K into cells
  • need to provide K once urinary flow is established
Monitoring
-hourly BG, ketones, VBG (pH), electrolytes (Na, K)
until
-patient alert
-ketoacidosis reversed
-tolerating oral fluids
Education
-review precipitating events
-symptoms and triggers of DKA
-self management during illness or reduce fluid intake
check BG and ketones often
maintain hydration
present to medical attention early
35
Q

Prognosis and complications DKA

A

approx 1% mortality
-usually due to precipitant

DKA related

  • gastrointestinal bleeding
  • oedema (pulmonary)

Treatment related

  • oedema (cerebral)
  • Thrombosis (venous)
  • Hypoglycaemia, hypokalaemia
36
Q

pathophys HHS

A

Decrease in insulin, increase in glucagon and other counter-regulatory hormones (cortisol, catecholamines, growth hormone). Decrease in insulin is less than DKA. Insulins inhibition of lipolysis is far greater than inhibition of gluconeogenesis, which is thought to explain absence of ketogenesis in HHS.

Decrease in hepatic fructose 2, 6-bisphosphate, which increases the activity of fructose-1, 6-bisphosphatase and decreases the activity of phosphofructokinase-1. Likewise, there is an increase in activity of phosphoenolpyruvate carboxykinase, and decrease for pyruvate kinase. Overall there is a shift in the handling of pyruvate towards gluconeogenesis and away from glycolysis.

At the same time, there is decrease expression GLUT-4, decrease glucose uptake, and an increase in glycogenolysis. Overall, marked increase in blood glucose, increasing plasma osmolality.

This draws water out of cells and increases ECF volume. Initially, this dilutes the electrolyte concentration in the blood. There is an osmotic diuresis of relatively electrolyte deficient water, thus increasing plasma osmolality.

37
Q

investigations HHS

A
Bedside:
glucose
-elevated (>45 mmol/L)
ABG/VBG
-mild acidosis (normal anion gap)
-bicarb may be marginally low
Dipstick
-glucosuria
-ketones may be present
Capillary ketones
-prefered
-may be present (but low)
Bloods
FBC
-leukocytosis
EUC and CMP
-elevated urea and creatinine (dehydration)
-Na low (1.5 for every 5.6)
-K normal or increased
-Ca, Ph, Mg low
-Lactate (normal)
-Lipids may be elevated
-LFTs (baseline, encephalopathy)

Consider:

  • blood, sputum, stool culture
  • urinalysis
  • chest xray
  • ECG and trops
  • tox screen
  • thiamine
  • EEG
38
Q

compare DKA and HHS

A

Note that they are thought to exist along a continuum

Demographic:

  • DKA = Type 1, younger, first presentation
  • HHS = elderly, Type 2

Triggers:

  • same
  • Dehydration and unable to tolerate oral fluids in elderly HHS

Symptoms:

  • onset more acute for DKA
  • both polyuria, polydypsia, weakness
  • DKA has nausea, vom, abdo pain
  • HHS notable lethargy, confusion, stupor

Signs:

  • dehydration for both
  • DKA = fruity breath, Kussmaul breathing
  • HHS = focal neuro signs and seizures

Investigations:

  • glucose >45 HHS, <35 DKA
  • pOsm variable in DKA, >320 mmol/kg in HHS
  • high anion gap acidosis more typical of DKA
  • ketones may be present in both, but higher level in DKA

Treatment:
-almost identical

Prognosis:

  • 1% mortality DKA
  • significantly higher for HHS (5-15%)
  • for both, usually due to underlying condition
  • higher rate in HHS may be related to older demographic
39
Q

diabetes monitoring/complication screening

A

Every 3-4 months

  • HbA1c
  • SMBG results
  • hyperglycaemia symptoms
  • hypoglycaemic episodes
  • dietary intake
  • exercise
  • weight
  • blood pressure
  • foot exam
  • injection sites
  • diabetes distress

Every 12 months

  • vitamin B12 (if on metformin)
  • peripheral neuropathy
  • retinopathy (may be 2 years)
  • UACR
  • lipid levels
  • smoking